Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$343,187,842
-$105,460,157 QoQ
Shares Held
5,658,497
-32.0% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50.663329855967056.ToString("F0")%
Shared 0.ToString("F0")%
None 49.336670144032944.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Mar 31, 2026CallValue
$909,750
CallShares
15,000
PutValue
$909,750
PutShares
15,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Man Group plc holds $1,645,149,077 across 10 Drug Manufacturers - General names. BMY ranks #3 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
422,016 | $388,157,656 | |
| 2 | ABBV |
AbbVie Inc.
|
1,774,415 | $385,917,516 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
5,658,497 | $343,187,842 | |
| 4 | AZN |
Astrazeneca PLC
|
628,476 | $123,948,035 | |
| 5 | MRK |
Merck & Co., Inc.
|
793,167 | $95,410,057 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
678,066 | $94,502,057 | |
| 7 | JNJ |
Johnson & Johnson
|
318,085 | $77,752,697 | |
| 8 | BIIB |
Biogen Inc.
|
318,745 | $58,435,520 |
All Filings in BMY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $343,187,842 | 5,658,497 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $909,750 | 15,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $909,750 | 15,000 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $809,100 | 15,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $448,647,999 | 8,317,538 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $809,100 | 15,000 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $416,190,015 | 9,228,160 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $345,593,964 | 7,465,845 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $119,690,067 | 1,962,454 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $97,742,862 | 1,728,127 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $167,120,819 | 3,230,012 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $194,729,932 | 4,688,898 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $99,058,251 | 1,826,632 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $112,598,511 | 2,194,475 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $15,440,495 | 266,032 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $33,181,862 | 518,872 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $32,430,841 | 467,910 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $58,708,680 | 815,965 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $43,429,590 | 610,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,082,211 | 325,743 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $16,057,980 | 219,882 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $41,727,050 | 669,239 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $75,209,861 | 1,271,081 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $55,691,727 | 833,459 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $122,635,136 | 1,942,581 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $208,938,004 | 3,368,338 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $250,098,835 | 4,148,264 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $209,589,777 | 3,564,452 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $63,364,449 | 1,136,786 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||